Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Seront

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Cancers|April 12, 2022
The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaHélène Houssiau, Emmanuel Seront
Translational Oncology|March 12, 2022
Improving the role of immune checkpoint inhibitors in the management of advanced urothelial carcinoma, where do we stand?Hélène Houssiau, Emmanuel Seront
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical ReviewFrançois Zammit, Emmanuel Seront
Recent Patents on Anti-Cancer Drug Discovery|June 13, 2009
Targeted therapies in the treatment of advanced renal cell carcinomaEmmanuel Seront, Jean-Pascal Machiels
Cancer Treatment Reviews|April 2, 2015
Molecular biology and targeted therapies for urothelial carcinomaEmmanuel Seront, Jean-Pascal Machiels
Urology Case Reports|June 4, 2020
Laparoscopic partial cystectomy for venous malformation of the bladderLea Radermecker, Stéphane Rysselinck, Emmanuel Seront
Frontiers in Oncology|December 24, 2021
Case Report: Early <sup>68</sup>Ga-PSMA-PET Metabolic Assessment and Response to Systemic Treatment for First-Line Metastatic Clear Cell Renal Cell Carcinoma; About Two Clinical CasesEmmanuel Seront, Renaud Lhommel, Bertrand Tombal
Otolaryngologic Clinics of North America|December 9, 2017
Venous Malformations of the Head and NeckEmmanuel Seront, Miikka Vikkula, Laurence M Boon
BMJ Case Reports|August 24, 2019
Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumabJulien Pierrard, Bénédicte Petit, Sarah Lejeune, et al.
BMJ Case Reports|January 29, 2016
Unusual presentation of bladder cancer resurgence and efficacy of radiotherapyRachel Galot, Nicolas Christian, Marie Bitar, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Cancers|April 12, 2022
The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaHélène Houssiau, Emmanuel Seront
Translational Oncology|March 12, 2022
Improving the role of immune checkpoint inhibitors in the management of advanced urothelial carcinoma, where do we stand?Hélène Houssiau, Emmanuel Seront
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical ReviewFrançois Zammit, Emmanuel Seront
Recent Patents on Anti-Cancer Drug Discovery|June 13, 2009
Targeted therapies in the treatment of advanced renal cell carcinomaEmmanuel Seront, Jean-Pascal Machiels
Cancer Treatment Reviews|April 2, 2015
Molecular biology and targeted therapies for urothelial carcinomaEmmanuel Seront, Jean-Pascal Machiels
Urology Case Reports|June 4, 2020
Laparoscopic partial cystectomy for venous malformation of the bladderLea Radermecker, Stéphane Rysselinck, Emmanuel Seront
Frontiers in Oncology|December 24, 2021
Case Report: Early <sup>68</sup>Ga-PSMA-PET Metabolic Assessment and Response to Systemic Treatment for First-Line Metastatic Clear Cell Renal Cell Carcinoma; About Two Clinical CasesEmmanuel Seront, Renaud Lhommel, Bertrand Tombal
Otolaryngologic Clinics of North America|December 9, 2017
Venous Malformations of the Head and NeckEmmanuel Seront, Miikka Vikkula, Laurence M Boon
BMJ Case Reports|August 24, 2019
Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumabJulien Pierrard, Bénédicte Petit, Sarah Lejeune, et al.
BMJ Case Reports|January 29, 2016
Unusual presentation of bladder cancer resurgence and efficacy of radiotherapyRachel Galot, Nicolas Christian, Marie Bitar, et al.
Pageof 8